Webappropriate concentration, while cisplatin (Ebewe Pharma, Unterach, Austria) was given undiluted. The administered volumes for cisplatin and cefepime ranged from 0.3 to 0.91 ml and from 0.3 to 0.35 ml, respectively. Experimental procedure Cisplatin was administered in 10, 14, 18, 22 and 26 mg/kg doses; the control group received saline. Cisplatin (cis-Diammindichloridoplatin; DDP) ist ein Arzneistoff (Zytostatikum zur Hemmung des Zellwachstums bzw. der Zellteilung) und enthält ein komplexgebundenes Platinatom. Die Wirkung beruht auf einer Hemmung der DNA-Replikation durch Querverknüpfungen zweier benachbarter … See more Cisplatin wurde zuerst 1844 von Michele Peyrone synthetisiert, damals bekannt als Peyrones Chlorid. Es spielte eine Rolle bei der Entwicklung der Komplexchemie durch Alfred Werner. Die Entdeckung der zytostatischen … See more Wirkungsmechanismus Cisplatin wirkt ähnlich wie bifunktionelle Alkylantien durch Querverknüpfungen von DNA-Strängen. Der stark elektrophile Aqua-Cisplatin … See more • Markus Galanski, Bernhard K. Keppler: Tumorhemmende Metallverbindungen. In: Pharmazie in unserer Zeit 35(2), S. 118–122 (2006), See more Cisplatin stellt einen planaren Komplex dar, der am zentralen Platinatom zwei cis-ständige Chloridliganden und zwei Amminliganden … See more Monopräparate Cis-GRY (D), Platiblastin (CH), Platinol (CH), zahlreiche Generika (D, A, CH). See more
The effect of different doses of cisplatin on the …
WebCisplatin or (SP-4-2)-diamminedichloridoplatinum(II) is one of the most potential and widely used drugs for the treatment of various solid cancers such as testicular, ovarian, head and neck, bladder, lung, cervical cancer, melanoma, lymphomas and several others. Cisplatin exerts anticancer activity … Cisplatin: The first metal based anticancer drug WebCisplatin has shown activity against osteosarcoma, transitional cell carcinoma, squamous cell carcinoma (SCC), melanoma, mesothelioma, carcinomatosis and germinal cell tumours in the dog. In the cat, cisplatin cannot be utilized because of fulminant pulmonary oedema that occurs at standard doses. dhs new board
Cisplatin (chemotherapy drug) - treatment and side effects
WebJun 16, 2008 · Concentration-dependent assays were carried out in DMEM containing cisplatin at concentrations up to 1,000 μmol/L. The fraction unbound Pt in DMEM, determined using equilibrium dialysis, was found to range between 10% and 26% at total cisplatin concentrations of 50 and 1,000 μmol/L, respectively. WebMaterial Name: Cisplatin Solution for Injection - 0.5 and 1 mg/ml Revision date: 02-Jan-2007 Page 7 of 7 Version: 1.1 16. OTHER INFORMATION Reasons for Revision: … WebCisplatin is a platinum-based agent whose nephrotoxicity is thought related to the chloride in the cis position. Cisplatin gains entry into tubular cells via uptake by the OCT-2 … dhs newborn screening